[MYGN] QoQ Quarter Result on 31-Mar-2012 [#Q1]

Stock
[MYGN] Myriad Genetics, Inc.
Announcement Date
02-May-2012
Financial Year
2012
Quarter
31-Mar-2012 [#Q1]
Profit Trend
QoQ- 4.66%
YoY- 5.99%
Quarter Report
MYGN's Result
MYGN's Financial Summary
View:
Show?
Quarter Result
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
Revenue 149,140 133,437 132,965 129,777 122,811 110,452 107,412 24.33%
PBT 56,985 49,822 48,471 47,481 46,783 41,805 42,107 22.23%
Tax 21,949 19,686 19,330 17,866 18,487 16,706 16,067 23.00%
NP 35,036 30,136 29,141 29,615 28,296 25,099 26,040 21.76%
Tax Rate -38.52% -39.51% -39.88% -37.63% -39.52% -39.96% -38.16% -
Total Cost 114,104 103,301 103,824 100,162 94,515 85,353 81,372 25.15%
Ratio Analysis
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
NP Margin 23.49 22.58 21.92 22.82 23.04 22.72 24.24 -2.06%
Per Share
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
EPS 0.43 0.37 0.35 0.35 0.33 0.29 0.00 -
EPS Diluted 0.42 0.36 0.34 0.34 0.33 0.29 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.